돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 408553생성일: 2026년 10월 26일

Piperidine → 2-Methyl-4-(3-methyl-1H-indazol-5-yl)-5-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrile

https://huagongshe.com/reaction/408553

반응식

참여 물질

역할이름HCID투입량
반응물PiperidineHCID 8082—
반응물3-Amino-2-butenenitrileHCID 70699—
반응물1,3-CyclopentanedioneHCID 77466—
반응물HCID 178434286HCID 178434286—
용매EthanolHCID 702—
생성물2-Methyl-4-(3-methyl-1H-indazol-5-yl)-5-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrileHCID 178428408—

반응 단계

91 mg (0.936 mmol) cyclopentane-1,3-dione, 150 mg (0.936 mmol) 3-methyl-1H-indazole-5-carbaldehyde (Example 1A) and piperidine (0.1 ml) in ethanol (8 ml) were heated to reflux for 1.5 h and then left standing without stirring at room temperature overnight. The mixture was then evaporated to dryness, the remaining solid was dissolved in acetic acid (8 ml), and 77 mg (0.936 mmol) 3-aminobut-2-enenitrile were added. The solution was heated to reflux for 2 h. After cooling, the mixture was evaporated to dryness again, and the remaining solid was purified by preparative RP-HPLC (acetonitrile/water gradient) to yield 34 mg (12% of th.) of the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08759341B2
출처 데이터셋uspto-grants-2014_06
ORD IDord-b93d4ba8a0d4431393c9f3b4ca172a6b
출처 메모uspto-grants-2014_06